0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Tardive Dyskinesia Market Research Report 2023
Published Date: April 2023
|
Report Code: QYRE-Auto-38S5955
Home | Market Reports | Health| Mental Health
Global Tardive Dyskinesia Market Insights Forecast to 2028
BUY CHAPTERS

Global Tardive Dyskinesia Market Research Report 2023

Code: QYRE-Auto-38S5955
Report
April 2023
Pages:67
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Global Tardive Dyskinesia Market

Tardive Dyskinesia (TD) market is estimated to post significant growth in coming years, owing to rising schizophrenia patients, increasing bipolar patients, growing antipsychotic prescription and increasing incidence of neurological disorders.
The global Tardive Dyskinesia market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The key factors driving the growth of the Tardive dyskinesia market are rising schizophrenia patients, increasing bipolar patients, growing antipsychotic prescription, increased use of long-term neuroleptic drugs and increasing incidence of neurological disorders. However, the expansion of the market is hindered by side effects of drugs and under-diagnosed.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Tardive Dyskinesia, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tardive Dyskinesia.
The Tardive Dyskinesia market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Tardive Dyskinesia market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Tardive Dyskinesia companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

Key Segmentations

By Company

  • Bausch Health
  • Neurocrine Biosciences
  • Teva Pharmaceuticals Industries

Segment by Type

  • Dopamine-Depleting Medications
  • GABA Receptor Agonist Medications
  • Anticholinergic Medications

Segment by Application

  • Hospitals
  • Ambulatory Surgical Centers
  • Diagnostic Centers

By Region

  • North America
  • United States
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Russia
  • Nordic Countries
  • Rest of Europe
  • Asia-Pacific
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Australia
  • Rest of Asia
  • Latin America
  • Mexico
  • Brazil
  • Rest of Latin America
  • Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE
  • Rest of MEA

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Tardive Dyskinesia companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

Scope of Global Tardive Dyskinesia Market Report

Report MetricDetails
Report NameGlobal Tardive Dyskinesia Market
Base Year2022
Forecasted years2023-2029
Forecast unitsUSD
Report coverageRevenue and volume forecast, company share, competitive landscape, growth factors and trends
Geographic regions coveredNorth America, Europe, Asia Pacific, Latin America, Middle East & Africa
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Tardive Dyskinesia Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Dopamine-Depleting Medications
1.2.3 GABA Receptor Agonist Medications
1.2.4 Anticholinergic Medications
1.3 Market by Application
1.3.1 Global Tardive Dyskinesia Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Diagnostic Centers
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Tardive Dyskinesia Market Perspective (2018-2029)
2.2 Tardive Dyskinesia Growth Trends by Region
2.2.1 Global Tardive Dyskinesia Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Tardive Dyskinesia Historic Market Size by Region (2018-2023)
2.2.3 Tardive Dyskinesia Forecasted Market Size by Region (2024-2029)
2.3 Tardive Dyskinesia Market Dynamics
2.3.1 Tardive Dyskinesia Industry Trends
2.3.2 Tardive Dyskinesia Market Drivers
2.3.3 Tardive Dyskinesia Market Challenges
2.3.4 Tardive Dyskinesia Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Tardive Dyskinesia Players by Revenue
3.1.1 Global Top Tardive Dyskinesia Players by Revenue (2018-2023)
3.1.2 Global Tardive Dyskinesia Revenue Market Share by Players (2018-2023)
3.2 Global Tardive Dyskinesia Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Tardive Dyskinesia Revenue
3.4 Global Tardive Dyskinesia Market Concentration Ratio
3.4.1 Global Tardive Dyskinesia Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Tardive Dyskinesia Revenue in 2022
3.5 Tardive Dyskinesia Key Players Head office and Area Served
3.6 Key Players Tardive Dyskinesia Product Solution and Service
3.7 Date of Enter into Tardive Dyskinesia Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Tardive Dyskinesia Breakdown Data by Type
4.1 Global Tardive Dyskinesia Historic Market Size by Type (2018-2023)
4.2 Global Tardive Dyskinesia Forecasted Market Size by Type (2024-2029)
5 Tardive Dyskinesia Breakdown Data by Application
5.1 Global Tardive Dyskinesia Historic Market Size by Application (2018-2023)
5.2 Global Tardive Dyskinesia Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Tardive Dyskinesia Market Size (2018-2029)
6.2 North America Tardive Dyskinesia Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Tardive Dyskinesia Market Size by Country (2018-2023)
6.4 North America Tardive Dyskinesia Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Tardive Dyskinesia Market Size (2018-2029)
7.2 Europe Tardive Dyskinesia Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Tardive Dyskinesia Market Size by Country (2018-2023)
7.4 Europe Tardive Dyskinesia Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Tardive Dyskinesia Market Size (2018-2029)
8.2 Asia-Pacific Tardive Dyskinesia Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Tardive Dyskinesia Market Size by Region (2018-2023)
8.4 Asia-Pacific Tardive Dyskinesia Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Tardive Dyskinesia Market Size (2018-2029)
9.2 Latin America Tardive Dyskinesia Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Tardive Dyskinesia Market Size by Country (2018-2023)
9.4 Latin America Tardive Dyskinesia Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Tardive Dyskinesia Market Size (2018-2029)
10.2 Middle East & Africa Tardive Dyskinesia Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Tardive Dyskinesia Market Size by Country (2018-2023)
10.4 Middle East & Africa Tardive Dyskinesia Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bausch Health
11.1.1 Bausch Health Company Detail
11.1.2 Bausch Health Business Overview
11.1.3 Bausch Health Tardive Dyskinesia Introduction
11.1.4 Bausch Health Revenue in Tardive Dyskinesia Business (2018-2023)
11.1.5 Bausch Health Recent Development
11.2 Neurocrine Biosciences
11.2.1 Neurocrine Biosciences Company Detail
11.2.2 Neurocrine Biosciences Business Overview
11.2.3 Neurocrine Biosciences Tardive Dyskinesia Introduction
11.2.4 Neurocrine Biosciences Revenue in Tardive Dyskinesia Business (2018-2023)
11.2.5 Neurocrine Biosciences Recent Development
11.3 Teva Pharmaceuticals Industries
11.3.1 Teva Pharmaceuticals Industries Company Detail
11.3.2 Teva Pharmaceuticals Industries Business Overview
11.3.3 Teva Pharmaceuticals Industries Tardive Dyskinesia Introduction
11.3.4 Teva Pharmaceuticals Industries Revenue in Tardive Dyskinesia Business (2018-2023)
11.3.5 Teva Pharmaceuticals Industries Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global Tardive Dyskinesia Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
    Table 2. Key Players of Dopamine-Depleting Medications
    Table 3. Key Players of GABA Receptor Agonist Medications
    Table 4. Key Players of Anticholinergic Medications
    Table 5. Global Tardive Dyskinesia Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
    Table 6. Global Tardive Dyskinesia Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 7. Global Tardive Dyskinesia Market Size by Region (2018-2023) & (US$ Million)
    Table 8. Global Tardive Dyskinesia Market Share by Region (2018-2023)
    Table 9. Global Tardive Dyskinesia Forecasted Market Size by Region (2024-2029) & (US$ Million)
    Table 10. Global Tardive Dyskinesia Market Share by Region (2024-2029)
    Table 11. Tardive Dyskinesia Market Trends
    Table 12. Tardive Dyskinesia Market Drivers
    Table 13. Tardive Dyskinesia Market Challenges
    Table 14. Tardive Dyskinesia Market Restraints
    Table 15. Global Tardive Dyskinesia Revenue by Players (2018-2023) & (US$ Million)
    Table 16. Global Tardive Dyskinesia Market Share by Players (2018-2023)
    Table 17. Global Top Tardive Dyskinesia Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tardive Dyskinesia as of 2022)
    Table 18. Ranking of Global Top Tardive Dyskinesia Companies by Revenue (US$ Million) in 2022
    Table 19. Global 5 Largest Players Market Share by Tardive Dyskinesia Revenue (CR5 and HHI) & (2018-2023)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Tardive Dyskinesia Product Solution and Service
    Table 22. Date of Enter into Tardive Dyskinesia Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Tardive Dyskinesia Market Size by Type (2018-2023) & (US$ Million)
    Table 25. Global Tardive Dyskinesia Revenue Market Share by Type (2018-2023)
    Table 26. Global Tardive Dyskinesia Forecasted Market Size by Type (2024-2029) & (US$ Million)
    Table 27. Global Tardive Dyskinesia Revenue Market Share by Type (2024-2029)
    Table 28. Global Tardive Dyskinesia Market Size by Application (2018-2023) & (US$ Million)
    Table 29. Global Tardive Dyskinesia Revenue Market Share by Application (2018-2023)
    Table 30. Global Tardive Dyskinesia Forecasted Market Size by Application (2024-2029) & (US$ Million)
    Table 31. Global Tardive Dyskinesia Revenue Market Share by Application (2024-2029)
    Table 32. North America Tardive Dyskinesia Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 33. North America Tardive Dyskinesia Market Size by Country (2018-2023) & (US$ Million)
    Table 34. North America Tardive Dyskinesia Market Size by Country (2024-2029) & (US$ Million)
    Table 35. Europe Tardive Dyskinesia Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 36. Europe Tardive Dyskinesia Market Size by Country (2018-2023) & (US$ Million)
    Table 37. Europe Tardive Dyskinesia Market Size by Country (2024-2029) & (US$ Million)
    Table 38. Asia-Pacific Tardive Dyskinesia Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 39. Asia-Pacific Tardive Dyskinesia Market Size by Region (2018-2023) & (US$ Million)
    Table 40. Asia-Pacific Tardive Dyskinesia Market Size by Region (2024-2029) & (US$ Million)
    Table 41. Latin America Tardive Dyskinesia Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 42. Latin America Tardive Dyskinesia Market Size by Country (2018-2023) & (US$ Million)
    Table 43. Latin America Tardive Dyskinesia Market Size by Country (2024-2029) & (US$ Million)
    Table 44. Middle East & Africa Tardive Dyskinesia Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 45. Middle East & Africa Tardive Dyskinesia Market Size by Country (2018-2023) & (US$ Million)
    Table 46. Middle East & Africa Tardive Dyskinesia Market Size by Country (2024-2029) & (US$ Million)
    Table 47. Bausch Health Company Detail
    Table 48. Bausch Health Business Overview
    Table 49. Bausch Health Tardive Dyskinesia Product
    Table 50. Bausch Health Revenue in Tardive Dyskinesia Business (2018-2023) & (US$ Million)
    Table 51. Bausch Health Recent Development
    Table 52. Neurocrine Biosciences Company Detail
    Table 53. Neurocrine Biosciences Business Overview
    Table 54. Neurocrine Biosciences Tardive Dyskinesia Product
    Table 55. Neurocrine Biosciences Revenue in Tardive Dyskinesia Business (2018-2023) & (US$ Million)
    Table 56. Neurocrine Biosciences Recent Development
    Table 57. Teva Pharmaceuticals Industries Company Detail
    Table 58. Teva Pharmaceuticals Industries Business Overview
    Table 59. Teva Pharmaceuticals Industries Tardive Dyskinesia Product
    Table 60. Teva Pharmaceuticals Industries Revenue in Tardive Dyskinesia Business (2018-2023) & (US$ Million)
    Table 61. Teva Pharmaceuticals Industries Recent Development
    Table 62. Research Programs/Design for This Report
    Table 63. Key Data Information from Secondary Sources
    Table 64. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Tardive Dyskinesia Market Size Comparison by Type (2023-2029) & (US$ Million)
    Figure 2. Global Tardive Dyskinesia Market Share by Type: 2022 VS 2029
    Figure 3. Dopamine-Depleting Medications Features
    Figure 4. GABA Receptor Agonist Medications Features
    Figure 5. Anticholinergic Medications Features
    Figure 6. Global Tardive Dyskinesia Market Size Comparison by Application (2023-2029) & (US$ Million)
    Figure 7. Global Tardive Dyskinesia Market Share by Application: 2022 VS 2029
    Figure 8. Hospitals Case Studies
    Figure 9. Ambulatory Surgical Centers Case Studies
    Figure 10. Diagnostic Centers Case Studies
    Figure 11. Tardive Dyskinesia Report Years Considered
    Figure 12. Global Tardive Dyskinesia Market Size (US$ Million), Year-over-Year: 2018-2029
    Figure 13. Global Tardive Dyskinesia Market Size, (US$ Million), 2018 VS 2022 VS 2029
    Figure 14. Global Tardive Dyskinesia Market Share by Region: 2022 VS 2029
    Figure 15. Global Tardive Dyskinesia Market Share by Players in 2022
    Figure 16. Global Top Tardive Dyskinesia Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tardive Dyskinesia as of 2022)
    Figure 17. The Top 10 and 5 Players Market Share by Tardive Dyskinesia Revenue in 2022
    Figure 18. North America Tardive Dyskinesia Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 19. North America Tardive Dyskinesia Market Share by Country (2018-2029)
    Figure 20. United States Tardive Dyskinesia Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 21. Canada Tardive Dyskinesia Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 22. Europe Tardive Dyskinesia Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 23. Europe Tardive Dyskinesia Market Share by Country (2018-2029)
    Figure 24. Germany Tardive Dyskinesia Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 25. France Tardive Dyskinesia Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 26. U.K. Tardive Dyskinesia Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 27. Italy Tardive Dyskinesia Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 28. Russia Tardive Dyskinesia Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 29. Nordic Countries Tardive Dyskinesia Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 30. Asia-Pacific Tardive Dyskinesia Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 31. Asia-Pacific Tardive Dyskinesia Market Share by Region (2018-2029)
    Figure 32. China Tardive Dyskinesia Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 33. Japan Tardive Dyskinesia Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 34. South Korea Tardive Dyskinesia Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 35. Southeast Asia Tardive Dyskinesia Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 36. India Tardive Dyskinesia Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 37. Australia Tardive Dyskinesia Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 38. Latin America Tardive Dyskinesia Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 39. Latin America Tardive Dyskinesia Market Share by Country (2018-2029)
    Figure 40. Mexico Tardive Dyskinesia Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 41. Brazil Tardive Dyskinesia Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 42. Middle East & Africa Tardive Dyskinesia Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 43. Middle East & Africa Tardive Dyskinesia Market Share by Country (2018-2029)
    Figure 44. Turkey Tardive Dyskinesia Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 45. Saudi Arabia Tardive Dyskinesia Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 46. Bausch Health Revenue Growth Rate in Tardive Dyskinesia Business (2018-2023)
    Figure 47. Neurocrine Biosciences Revenue Growth Rate in Tardive Dyskinesia Business (2018-2023)
    Figure 48. Teva Pharmaceuticals Industries Revenue Growth Rate in Tardive Dyskinesia Business (2018-2023)
    Figure 49. Bottom-up and Top-down Approaches for This Report
    Figure 50. Data Triangulation
    Figure 51. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String

SIMILAR REPORTS